South Africa

5 Vaccines Approved for Use in South Africa

RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
84 trials in 27 countries
Approval Source: sahpra.org.za
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: forbes.com
Non Replicating Viral Vector

Serum Institute of India

Covishield (Oxford/ AstraZeneca formulation)

Approved in 49 countries
4 trials in 1 country
Approval Source: indiatoday.in
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 91 countries
30 trials in 12 countries
Approval Source: reuters.com
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
37 trials in 9 countries
Approval Source: bloomberg.com

15 in Clinical Trials in South Africa

Protein Subunit

Novavax

Nuvaxovid

Approved in 37 countries
16 trials in 12 countries
RNA

Moderna

Spikevax

Approved in 86 countries
67 trials in 23 countries
RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
84 trials in 27 countries
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
64 trials in 31 countries
Non Replicating Viral Vector

ReiThera

GRAd-COV2

5 trials in 12 countries
RNA

Pfizer/BioNTech

BNT162b2 (B.1.1.7)

RNA

Pfizer/BioNTech

BNT162b2 (B.1.1.7 + B.1.617.2)

RNA

Pfizer/BioNTech

BNT162b2 (B.1.617.2)

RNA

Providence Therapeutics Holdings Inc.

PTX-COVID19-B

2 trials in 2 countries
Non Replicating Viral Vector

ImmunityBio Inc

hAd5-Covid-19

7 trials in 2 countries
DNA

Scancell

COVIDITY

RNA

ImmunityBio Inc

AAHI-SC2 Vaccine

2 trials in 1 country
RNA

ImmunityBio Inc

AAHI-SC3 Vaccine

2 trials in 1 country
Protein Subunit

Clover

SCB-2019

14 trials in 13 countries